Page last updated: 2024-10-16

carbamates and Debility

carbamates has been researched along with Debility in 1 studies

Research Excerpts

ExcerptRelevanceReference
"In elderly HCV patients, poor frailty status strongly predicted new LTCI certification after DAA therapy."1.62Frailty Status Predicts New Long-term Care Insurance Certification in Hepatitis C Patients Receiving Antiviral Therapy. ( Hasuike, S; Iwakiri, H; Kuroki, K; Kusumoto, K; Matsuura, Y; Mukuda, T; Nagata, K; Nakamura, K; Ochiai, T; Ozono, Y; Shimoda, K; Tsuchimochi, M, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nakamura, K1
Kusumoto, K1
Ozono, Y1
Kuroki, K1
Matsuura, Y1
Mukuda, T1
Ochiai, T1
Tsuchimochi, M1
Iwakiri, H1
Hasuike, S1
Shimoda, K1
Nagata, K1

Other Studies

1 other study available for carbamates and Debility

ArticleYear
Frailty Status Predicts New Long-term Care Insurance Certification in Hepatitis C Patients Receiving Antiviral Therapy.
    Anticancer research, 2021, Volume: 41, Issue:8

    Topics: Aged; Aged, 80 and over; Antiviral Agents; Carbamates; Eligibility Determination; Female; Frailty; H

2021